TET2 and acute myeloid leukemia: The largest and most recent analysis of the order of mutation acquisition was conducted using 1540 de novo AML samples and validated the previous identification of DNMT3A, ASXL1, IDH2, and TET2 as the earliest mutations in sporadic AML (Papaemmanuil et al., 2016).